The Priority Review

Tag

PTCy

1 story

Stories

  1. Clinical trials

    Authors find no link between engraftment microbiome diversity and non-relapse mortality

    The authors of a Phase III trial published in Nature Medicine reported no association between engraftment microbiome diversity and non-relapse mortality after 1 year (P = 0.314). They also found that lower baseline microbiome diversity was associated with shorter overall survival (P = 0.007).